These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38888696)

  • 1. The Role of Reverse Cascade Screening in Children with Familial Hypercholesterolemia: A Literature Review and Analysis.
    Lokkesmoe R; Hamilton L
    Curr Atheroscler Rep; 2024 Aug; 26(8):427-433. PubMed ID: 38888696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reverse Cascade Screening for Familial Hypercholesterolemia.
    Vinson A; Guerra L; Hamilton L; Wilson DP; Fnla
    J Pediatr Nurs; 2019; 44():50-55. PubMed ID: 30683281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Universal screening for familial hypercholesterolemia in children: The Slovenian model and literature review.
    Groselj U; Kovac J; Sustar U; Mlinaric M; Fras Z; Podkrajsek KT; Battelino T
    Atherosclerosis; 2018 Oct; 277():383-391. PubMed ID: 30270075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Atherosclerotic Cardiovascular Disease in Children with Familial Hypercholesterolemia.
    Peterson AL; McNeal CJ; Wilson DP
    Curr Atheroscler Rep; 2021 Aug; 23(10):64. PubMed ID: 34453222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In pediatric familial hypercholesterolemia, lipoprotein(a) is more predictive than LDL-C for early onset of cardiovascular disease in family members.
    Zawacki AW; Dodge A; Woo KM; Ralphe JC; Peterson AL
    J Clin Lipidol; 2018; 12(6):1445-1451. PubMed ID: 30150142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Algorithm for detection and screening of familial hypercholesterolemia in Lithuanian population.
    Aliosaitiene U; Petrulioniene Z; Rinkuniene E; Mainelis A; Brazdziuniene E; Smailyte U; Sileikiene V; Laucevicius A
    Lipids Health Dis; 2024 May; 23(1):136. PubMed ID: 38715054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cascade screening and genetic diagnosis of familial hypercholesterolemia in clusters of the Southeastern region from Brazil.
    de Paiva Silvino JP; Jannes CE; Tada MT; Lima IR; Silva IFO; Pereira AC; Gomes KB
    Mol Biol Rep; 2020 Dec; 47(12):9279-9288. PubMed ID: 33231818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic Testing for Familial Hypercholesterolemia: Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2022; 22(3):1-155. PubMed ID: 36158868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Lozano P; Henrikson NB; Dunn J; Morrison CC; Nguyen M; Blasi PR; Anderson ML; Whitlock EP
    JAMA; 2016 Aug; 316(6):645-55. PubMed ID: 27532919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal low density lipoprotein cholesterol goal achievement and cardiovascular outcomes among adult patients with familial hypercholesterolemia: The CASCADE FH registry.
    Duell PB; Gidding SS; Andersen RL; Knickelbine T; Anderson L; Gianos E; Shrader P; Kindt I; O'Brien EC; McCann D; Hemphill LC; Ahmed CD; Martin SS; Larry JA; Ahmad ZS; Kullo IJ; Underberg JA; Guyton J; Thompson P; Wilemon K; Roe MT; Rader DJ; Cuchel M; Linton MF; Shapiro MD; Moriarty PM; Knowles JW
    Atherosclerosis; 2019 Oct; 289():85-93. PubMed ID: 31487564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detecting familial hypercholesterolemia by serum lipid profile screening in a hospital setting: Clinical, genetic and atherosclerotic burden profile.
    Scicali R; Di Pino A; Platania R; Purrazzo G; Ferrara V; Giannone A; Urbano F; Filippello A; Rapisarda V; Farruggia E; Piro S; Rabuazzo AM; Purrello F
    Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):35-43. PubMed ID: 28958694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic testing for familial hypercholesterolemia: Impact on diagnosis, treatment and cardiovascular risk.
    Lee S; Akioyamen LE; Aljenedil S; Rivière JB; Ruel I; Genest J
    Eur J Prev Cardiol; 2019 Aug; 26(12):1262-1270. PubMed ID: 30755017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives from individuals with familial hypercholesterolemia on direct contact in cascade screening.
    Schwiter R; Brown E; Murray B; Kindt I; Van Enkevort E; Pollin TI; Sturm AC
    J Genet Couns; 2020 Dec; 29(6):1142-1150. PubMed ID: 32223038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective screening for familial hypercholesterolemia in Austrian children - first year results.
    Kreissl A; Walleczek N; Espina PR; Hallwirth U; Greber-Platzer S
    BMC Pediatr; 2019 Jun; 19(1):208. PubMed ID: 31238984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of Measuring Lipoprotein(a) During Cascade Testing for Familial Hypercholesterolemia.
    Ellis KL; Pérez de Isla L; Alonso R; Fuentes F; Watts GF; Mata P
    J Am Coll Cardiol; 2019 Mar; 73(9):1029-1039. PubMed ID: 30846097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.
    Nordestgaard BG; Chapman MJ; Humphries SE; Ginsberg HN; Masana L; Descamps OS; Wiklund O; Hegele RA; Raal FJ; Defesche JC; Wiegman A; Santos RD; Watts GF; Parhofer KG; Hovingh GK; Kovanen PT; Boileau C; Averna M; Borén J; Bruckert E; Catapano AL; Kuivenhoven JA; Pajukanta P; Ray K; Stalenhoef AF; Stroes E; Taskinen MR; Tybjærg-Hansen A;
    Eur Heart J; 2013 Dec; 34(45):3478-90a. PubMed ID: 23956253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial Hypercholesterolemia: A Narrative Review on Diagnosis and Management Strategies for Children and Adolescents.
    Tada H; Takamura M; Kawashiri MA
    Vasc Health Risk Manag; 2021; 17():59-67. PubMed ID: 33628029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.